review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Gu W | |
Kruse JP | |||
P2860 | cites work | A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation | Q22008779 |
Translating the Histone Code | Q22065840 | ||
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53 | Q22253350 | ||
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras | Q22254666 | ||
Negative control of p53 by Sir2alpha promotes cell survival under stress | Q24291828 | ||
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase | Q24291829 | ||
ASPP proteins specifically stimulate the apoptotic function of p53 | Q24291844 | ||
p53 is regulated by the lysine demethylase LSD1 | Q24292925 | ||
SUMO-1 and p53. | Q34995629 | ||
The p53-Mdm2 module and the ubiquitin system. | Q35036580 | ||
Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage | Q35071254 | ||
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation | Q35089377 | ||
Phosphorylation of serine 18 regulates distinct p53 functions in mice | Q35545143 | ||
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity | Q35610627 | ||
p300/CBP and cancer | Q35779695 | ||
The p53 response to DNA damage | Q35848498 | ||
Mdmx as an essential regulator of p53 activity | Q36113127 | ||
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. | Q36117542 | ||
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. | Q36347917 | ||
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. | Q36423924 | ||
Transcriptional regulation by p53: one protein, many possibilities | Q36436698 | ||
Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo | Q36436702 | ||
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition | Q36499146 | ||
The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain | Q36833807 | ||
The role of ubiquitination in the direct mitochondrial death program of p53. | Q36881193 | ||
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse | Q37331246 | ||
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. | Q37343700 | ||
Ubiquitination of p53 at multiple sites in the DNA-binding domain | Q37382534 | ||
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization | Q24292930 | ||
Monoubiquitylation promotes mitochondrial p53 translocation | Q24295012 | ||
Critical role for Daxx in regulating Mdm2 | Q24297332 | ||
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop | Q24297633 | ||
p53 has a direct apoptogenic role at the mitochondria | Q24298888 | ||
Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development | Q24300985 | ||
ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor | Q24306428 | ||
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis | Q24307994 | ||
DBC1 is a negative regulator of SIRT1 | Q24309055 | ||
Negative regulation of the deacetylase SIRT1 by DBC1 | Q24309090 | ||
Regulation of p53 activity through lysine methylation | Q24311514 | ||
Acetylation is indispensable for p53 activation | Q24313477 | ||
FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity | Q24314409 | ||
Repression of p53 activity by Smyd2-mediated methylation | Q24315991 | ||
A large-scale RNAi screen in human cells identifies new components of the p53 pathway | Q24319883 | ||
Mdm2 promotes the rapid degradation of p53 | Q24322597 | ||
The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex | Q24323508 | ||
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 | Q24328775 | ||
An essential function of the extreme C-terminus of MDM2 can be provided by MDMX | Q24328822 | ||
Modulation of p53 function by SET8-mediated methylation at lysine 382 | Q24337822 | ||
Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation | Q24338320 | ||
hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes | Q24338336 | ||
p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage | Q24530584 | ||
Regulation of p53 function and stability by phosphorylation | Q24554530 | ||
Two cellular proteins that bind to wild-type but not mutant p53 | Q24562261 | ||
Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition | Q24562892 | ||
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites | Q24610054 | ||
Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway | Q24648370 | ||
Regulation of autophagy by cytoplasmic p53 | Q24651258 | ||
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy | Q24651380 | ||
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 | ||
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 | ||
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain | Q27860534 | ||
Regulation of p53 stability by Mdm2 | Q27860744 | ||
p53, the cellular gatekeeper for growth and division | Q27860990 | ||
Surfing the p53 network | Q28032484 | ||
Arginine methylation regulates the p53 response | Q28116284 | ||
Deacetylation of p53 modulates its effect on cell growth and apoptosis | Q28138967 | ||
CBP/p300 in cell growth, transformation, and development | Q28140313 | ||
Regulation of HDM2 activity by the ribosomal protein L11 | Q28184745 | ||
Definition of a consensus binding site for p53 | Q28207794 | ||
Tumor suppression by Ink4a-Arf: progress and puzzles | Q28207959 | ||
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 | Q28214793 | ||
Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs | Q28246401 | ||
A dynamic role of HAUSP in the p53-Mdm2 pathway | Q28253645 | ||
Tumour suppression: disruption of HAUSP gene stabilizes p53 | Q28254102 | ||
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 | Q28254119 | ||
The ubiquitin ligase COP1 is a critical negative regulator of p53 | Q28258057 | ||
Divorcing ARF and p53: an unsettled case | Q28258356 | ||
Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53 | Q28265932 | ||
ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation | Q28265951 | ||
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas | Q28269089 | ||
Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity | Q28270986 | ||
Identification of p53 as a sequence-specific DNA-binding protein | Q28282745 | ||
ASPP [corrected] and cancer | Q28299046 | ||
p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60 | Q28304820 | ||
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation | Q28508240 | ||
Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. | Q28590239 | ||
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation | Q28609772 | ||
A global map of p53 transcription-factor binding sites in the human genome | Q29614400 | ||
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 | Q29614430 | ||
Cancer. p53, guardian of the genome | Q29615610 | ||
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas | Q29615658 | ||
Post-translational modifications and activation of p53 by genotoxic stresses | Q29615659 | ||
DNA damage activates p53 through a phosphorylation-acetylation cascade | Q29616294 | ||
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 | Q29617850 | ||
T antigen is bound to a host protein in SY40-transformed cells | Q29618321 | ||
p53 ubiquitination: Mdm2 and beyond | Q29619502 | ||
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice | Q29619786 | ||
p53 in health and disease | Q29619939 | ||
Nucleolar Arf sequesters Mdm2 and activates p53 | Q29620244 | ||
C-terminal ubiquitination of p53 contributes to nuclear export | Q33551236 | ||
Kinetics of p53 binding to promoter sites in vivo | Q33558659 | ||
Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells | Q33588694 | ||
p53 and human cancer: the first ten thousand mutations. | Q33767112 | ||
Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity | Q33863075 | ||
Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo | Q33896638 | ||
The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation | Q33900545 | ||
Stress signals utilize multiple pathways to stabilize p53 | Q33963268 | ||
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. | Q34170068 | ||
Mutation of mouse p53 Ser23 and the response to DNA damage | Q34277066 | ||
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. | Q34283106 | ||
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. | Q34312488 | ||
The central region of HDM2 provides a second binding site for p53. | Q34335012 | ||
The p53 proto-oncogene can act as a suppressor of transformation | Q34440370 | ||
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy | Q34478557 | ||
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. | Q34585107 | ||
Crippling p53 activities via knock-in mutations in mouse models | Q34614596 | ||
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network | Q34825957 | ||
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. | Q37524264 | ||
Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation | Q37543781 | ||
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors | Q38315892 | ||
Regulation of the specific DNA binding function of p53 | Q38324290 | ||
Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses | Q38351593 | ||
KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. | Q39859206 | ||
MSL2 promotes Mdm2-independent cytoplasmic localization of p53 | Q39912357 | ||
C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. | Q40157263 | ||
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells | Q40237209 | ||
Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation | Q40251109 | ||
Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. | Q40290190 | ||
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. | Q40323754 | ||
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells | Q40410781 | ||
The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. | Q40491393 | ||
Yin Yang 1 is a negative regulator of p53. | Q40542917 | ||
Inhibition of p53 degradation by Mdm2 acetylation | Q40580015 | ||
Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53. | Q40911280 | ||
Mdm2 and Mdm4 loss regulates distinct p53 activities | Q41269705 | ||
The N terminus of p53 regulates its dissociation from DNA. | Q42055738 | ||
Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression | Q42062886 | ||
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation | Q42816808 | ||
Acetylation of the p53 DNA-binding domain regulates apoptosis induction | Q43019120 | ||
SnapShot: p53 posttranslational modifications | Q43118019 | ||
Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. | Q43594592 | ||
Acetylation of p53 inhibits its ubiquitination by Mdm2. | Q44209228 | ||
Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication | Q44703400 | ||
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. | Q44896717 | ||
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis | Q45345472 | ||
The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality | Q46111122 | ||
Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. | Q52590496 | ||
Latent and active p53 are identical in conformation | Q58002479 | ||
Dual-site regulation of MDM2 E3-ubiquitin ligase activity | Q79954190 | ||
Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain | Q80826872 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 609-22 | |
P577 | publication date | 2009-05-15 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | Modes of p53 regulation | |
P478 | volume | 137 |
Q34568342 | 14-3-3Gamma inhibition of MDMX-mediated p21 turnover independent of p53. |
Q39725980 | 2,3,7,8-tetrachlorodibenzo-p-dioxin counteracts the p53 response to a genotoxicant by upregulating expression of the metastasis marker agr2 in the hepatocarcinoma cell line HepG2. |
Q39468621 | 53BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via Distinct Mechanisms |
Q98290896 | A 3D Cell Culture Model Identifies Wnt/β-Catenin Mediated Inhibition of p53 as a Critical Step during Human Hepatocyte Regeneration |
Q33976501 | A B56gamma mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A |
Q90304315 | A CD24-p53 axis contributes to African American prostate cancer disparities |
Q47101924 | A Dual Role of P53 in Regulating Colistin-Induced Autophagy in PC-12 Cells |
Q38721370 | A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18. |
Q38551928 | A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak·Bcl-xl Complex and Triggering Transcriptional Regulation |
Q45354033 | A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells |
Q47590835 | A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma |
Q35973676 | A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP. |
Q34509620 | A Small Ribosomal Subunit (SSU) Processome Component, the Human U3 Protein 14A (hUTP14A) Binds p53 and Promotes p53 Degradation |
Q94560972 | A Systems Biology Approach Identifies Hidden Regulatory Connections Between the Circadian and Cell-Cycle Checkpoints |
Q39472408 | A critical role for noncoding 5S rRNA in regulating Mdmx stability |
Q24600216 | A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network |
Q33591375 | A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells |
Q34540424 | A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. |
Q37982800 | A new PICTure of nucleolar stress. |
Q47074018 | A novel TRIM family member, Trim69, regulates zebrafish development through p53-mediated apoptosis |
Q39283910 | A novel approach to cancer treatment using structural hybrids of the p53 gene family. |
Q42214198 | A novel facet of tumor suppression by p53: Induction of tumor immunogenicity. |
Q55252904 | A novel isolation method for cancer prognostic factors via the p53 pathway by a combination of in vitro and in silico analyses. |
Q37834073 | A novel oncoprotein Pirh2: rising from the shadow of MDM2. |
Q34333807 | A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53 |
Q64101387 | A novel regulatory circuit between p53 and GFI1 controls induction of apoptosis in T cells |
Q92461144 | A nuclear phosphoinositide kinase complex regulates p53 |
Q37631219 | A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. |
Q36037994 | A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53. |
Q52705977 | A systems biology view of evolutionary genetics: network-driven processes incorporate much more variation than evolutionary genetics can handle. This variation is hard to formalise but allows fast change. |
Q33826269 | A theoretical exploration of birhythmicity in the p53-Mdm2 network |
Q34385189 | ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53. |
Q40143097 | AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway |
Q33588393 | AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations |
Q24314880 | AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis |
Q41167426 | AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells |
Q37546075 | AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity |
Q49247817 | APTM, a Thiophene Heterocyclic Compound, Inhibits Human Colon Cancer HCT116 Cell Proliferation Through p53-Dependent Induction of Apoptosis |
Q42143482 | ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma. |
Q39070125 | ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets |
Q24296257 | ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress |
Q36443372 | ATM and KAT5 safeguard replicating chromatin against formaldehyde damage. |
Q34517226 | ATM suppresses SATB1-induced malignant progression in breast epithelial cells |
Q42243995 | ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage |
Q42154715 | ATM-mediated phosphorylation of SOG1 is essential for the DNA damage response in Arabidopsis. |
Q33570731 | Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis |
Q37306546 | Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer |
Q36615629 | Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity |
Q37581391 | Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression |
Q27667596 | Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration |
Q24339569 | Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress |
Q27314528 | Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen |
Q37676920 | Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode |
Q34658173 | Actin polymerization negatively regulates p53 function by impairing its nuclear import in response to DNA damage. |
Q64106414 | Acting locally - affecting globally: RNA sequencing of gilthead sea bream with a mild Sparicotyle chrysophrii infection reveals effects on apoptosis, immune and hypoxia related genes |
Q42792438 | Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2 |
Q37141585 | Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype |
Q36304376 | Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance |
Q42409336 | Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl |
Q38619367 | Agmatine Ameliorates High Glucose-Induced Neuronal Cell Senescence by Regulating the p21 and p53 Signaling |
Q91856583 | Amniotic Fluid Cells, Stem Cells, and p53: Can We Stereotype p53 Functions? |
Q47374613 | Amorphous silica nanoparticles induce malignant transformation and tumorigenesis of human lung epithelial cells via P53 signaling |
Q35690429 | An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells |
Q27681154 | An Ultrahigh Affinity d -Peptide Antagonist Of MDM2 |
Q38038498 | An overview of transcriptional regulation in response to toxicological insult. |
Q36769000 | Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer |
Q48152470 | Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer |
Q64237823 | Annexin A2 Silencing Inhibits Proliferation and Epithelial-to-mesenchymal Transition through p53-Dependent Pathway in NSCLCs |
Q36294822 | Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. |
Q89065778 | Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway |
Q30523071 | Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity. |
Q55106818 | Antifibrogenic Influence of Mentha piperita L. Essential Oil against CCl4-Induced Liver Fibrosis in Rats. |
Q38285170 | Antitumor mechanisms when pRb and p53 are genetically inactivated |
Q35874908 | Apak competes with p53 for direct binding to intron 1 of p53AIP1 to regulate apoptosis. |
Q50571545 | Arabidopsis PHYTOCHROME INTERACTING FACTOR proteins promote phytochrome B polyubiquitination by COP1 E3 ligase in the nucleus. |
Q38724393 | Arsenic trioxide induces ROS activity and DNA damage, leading to G0/G1 extension in skin fibroblasts through the ATM-ATR-associated Chk pathway. |
Q38174500 | Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk |
Q42063067 | Association of SIRT1 and HMGA1 expression in non-small cell lung cancer |
Q34960791 | Association of the circadian factor Period 2 to p53 influences p53's function in DNA-damage signaling |
Q27675820 | Atomic Structure of Dual-Specificity Phosphatase 26, a Novel p53 Phosphatase |
Q39148631 | Attachment-regulated signaling networks in the fibroblast-populated 3D collagen matrix |
Q64990362 | Attenuation of autophagy flux by 6-shogaol sensitizes human liver cancer cells to TRAIL-induced apoptosis via p53 and ROS. |
Q30669518 | Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment |
Q24303987 | Aurora B Interacts with NIR-p53, Leading to p53 Phosphorylation in Its DNA-binding Domain and Subsequent Functional Suppression |
Q33739952 | Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma |
Q37732086 | Autophagy and the Cell Cycle: A Complex Landscape. |
Q36194770 | Autophagy is induced through the ROS-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition |
Q89078129 | BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation |
Q36121723 | BCLAF1 is a radiation-induced H2AX-interacting partner involved in γH2AX-mediated regulation of apoptosis and DNA repair |
Q37205871 | BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer. |
Q47164914 | BTK blocks the inhibitory effects of MDM2 on p53 activity |
Q34414003 | Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. |
Q38282236 | Battle against cancer: an everlasting saga of p53. |
Q38129174 | Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy |
Q39652443 | Benzo(a)pyrene induces p73 mRNA expression and necrosis in human lung adenocarcinoma H1299 cells |
Q34621019 | Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma |
Q27675410 | Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein |
Q34158315 | Bioinformatics study of cancer-related mutations within p53 phosphorylation site motifs |
Q21129361 | Btg1 is Required to Maintain the Pool of Stem and Progenitor Cells of the Dentate Gyrus and Subventricular Zone |
Q35128538 | Bystander communication and cell cycle decisions after DNA damage |
Q42323430 | C23 promotes tumorigenesis via suppressing p53 activity |
Q49166463 | CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer |
Q27317294 | CEP-1, the Caenorhabditis elegans p53 homolog, mediates opposing longevity outcomes in mitochondrial electron transport chain mutants |
Q45997551 | CITED2 affects leukemic cell survival by interfering with p53 activation. |
Q39619078 | CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid |
Q38911627 | CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo |
Q21245061 | Cancer as a metabolic disease |
Q33755908 | Cancer stem cell theory and the warburg effect, two sides of the same coin? |
Q40859595 | Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance |
Q47110552 | Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit |
Q24310683 | Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop |
Q39286948 | Caught in the act - protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease |
Q28483080 | Ccdc94 protects cells from ionizing radiation by inhibiting the expression of p53 |
Q36697632 | Cell Differentiation and Checkpoint |
Q28830783 | Cell signaling, post-translational protein modifications and NMR spectroscopy |
Q60300970 | Cell type-dependent bimodal p53 activation engenders a dynamic mechanism of chemoresistance |
Q39321805 | Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1. |
Q54646381 | Cellular localization of human p53 expressed in the yeast Saccharomyces cerevisiae: effect of NLSI deletion. |
Q39254584 | Centrosome aberrations associated with cellular senescence and p53 localization at supernumerary centrosomes |
Q36860342 | Cerebellum Development and Tumorigenesis: A p53-Centric Perspective |
Q57801746 | Chromatin-remodeling factor, RSF1, controls p53-mediated transcription in apoptosis upon DNA strand breaks |
Q39112125 | Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry |
Q38696332 | Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. |
Q27002356 | Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer |
Q35926350 | Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin |
Q34178769 | Conditional inactivation of PDCD2 induces p53 activation and cell cycle arrest |
Q36249459 | Conformational selection and induced fit for RNA polymerase and RNA/DNA hybrid backtracked recognition |
Q36655948 | Connecting chromatin modifying factors to DNA damage response |
Q34487653 | Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53 |
Q34011009 | Controlling the Mdm2-Mdmx-p53 Circuit |
Q34621458 | Cooperative actions of p21WAF1 and p53 induce Slug protein degradation and suppress cell invasion |
Q38984847 | Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters |
Q89608997 | Crotonylation at serine 46 impairs p53 activity |
Q64973191 | Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects. |
Q38961549 | Curcumin homing to the nucleolus: mechanism for initiation of an apoptotic program |
Q47779642 | Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling |
Q39534965 | Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro |
Q46311981 | Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma |
Q53228284 | Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis. |
Q49732484 | Cytotoxic Profiling of Plant Secondary Metabolites on P53 Variant Human Colon Carcinoma Cell Lines |
Q35170092 | DECOD: fast and accurate discriminative DNA motif finding |
Q30842780 | DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression. |
Q34783261 | DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control |
Q90595521 | DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism |
Q38695071 | Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint |
Q34368142 | Deconstructing nucleotide binding activity of the Mdm2 RING domain |
Q41908765 | Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors |
Q36251554 | Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease |
Q90739234 | Dephosphorylation of p53 Ser 392 Enhances Trimethylation of Histone H3 Lys 9 via SUV39h1 Stabilization in CK2 Downregulation-Mediated Senescence |
Q36736875 | Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway. |
Q27003153 | Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1 |
Q28117749 | Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis |
Q38448653 | Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions |
Q36556345 | Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy |
Q33531524 | Differences in the transactivation domains of p53 family members: a computational study |
Q33923989 | Differential DNA damage responses in p53 proficient and deficient cells: cisplatin-induced nuclear import of XPA is independent of ATR checkpoint in p53-deficient lung cancer cells. |
Q61814274 | Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells |
Q35571311 | Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90. |
Q39053392 | Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines |
Q58761872 | Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells |
Q35040623 | Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells |
Q38943429 | Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells |
Q90575977 | Dissenting degradation: Deubiquitinases in cell cycle and cancer |
Q35737507 | Distinct p53 genomic binding patterns in normal and cancer-derived human cells |
Q35892477 | Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells |
Q42246401 | Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function |
Q38341405 | Doubles Game: Src-Stat3 versus p53-PTEN in Cellular Migration and Invasion |
Q33816125 | Downmodulation of tumor suppressor p53 by T cell receptor signaling is critical for antigen-specific CD4(+) T cell responses |
Q38796554 | Dracorhodin perchlorate induces the apoptosis of glioma cells |
Q42274730 | Drosophila p53 Is Required to Increase the Levels of the dKDM4B Demethylase after UV-induced DNA Damage to Demethylate Histone H3 Lysine 9 |
Q38191796 | Drugging the p53 pathway: understanding the route to clinical efficacy |
Q36387594 | Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity |
Q90542956 | Dual regulation of p53 by the ribosome maturation factor SBDS |
Q24324162 | Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma |
Q42050873 | Dynamic reprogramming of chromatin: paradigmatic palimpsests and HES factors |
Q33679142 | Dynamics of posttranslational modifications of p53. |
Q91750497 | Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells |
Q34684950 | E2 ligase dRad6 regulates DMP53 turnover in Drosophila |
Q34869507 | EDD inhibits ATM-mediated phosphorylation of p53. |
Q55421291 | ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function. |
Q24630090 | Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck |
Q38152281 | Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis |
Q42381105 | Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death |
Q38934408 | Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor |
Q28535332 | Electrostatically accelerated encounter and folding for facile recognition of intrinsically disordered proteins |
Q47121243 | Elevated p53 Activities Restrict Differentiation Potential of MicroRNA-Deficient Pluripotent Stem Cells |
Q38092575 | Emerging roles for chromatin as a signal integration and storage platform |
Q42182800 | Emerging roles of p53 in glial cell function in health and disease. |
Q39352250 | Emodin regulates apoptotic pathway in human liver cancer cells |
Q45885573 | Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer |
Q34360157 | Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice |
Q28079434 | Epigenetics of Renal Development and Disease |
Q43541896 | Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival |
Q59352774 | Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression |
Q60915934 | Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells |
Q34557122 | Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3'-end processing and function during DNA damage. |
Q39710961 | Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy |
Q58743588 | Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation |
Q31121002 | Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity |
Q28025433 | Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes |
Q39149681 | Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteins |
Q48292871 | Evidence for a radiation-responsive 'p53 gateway' contributing significantly to the radioresistance of lepidopteran insect cells |
Q53609777 | Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity. |
Q42476896 | Exploring a minimal two-component p53 model |
Q50117885 | Expression of TP53 and IL-1α in unicystic ameloblastoma predicts the efficacy of marsupialization treatment |
Q92528246 | Expression of the Major and Pro-Oncogenic H3K9 Lysine Methyltransferase SETDB1 in Non-Small Cell Lung Cancer |
Q37281807 | Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process. |
Q37428803 | Extensive post-translational modification of active and inactivated forms of endogenous p53. |
Q59791984 | Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis |
Q34043533 | Ferroptosis as a p53-mediated activity during tumour suppression |
Q35098597 | Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity |
Q36937240 | Folded Conformation, Cyclic Pentamer, Nano-Structure and PAD4 Binding Mode of YW3-56. |
Q47128100 | Forkhead Box O3A (FOXO3) and the Mitochondrial Disulfide Relay Carrier (CHCHD4) Regulate p53 Protein Nuclear Activity in Response to Exercise |
Q27678684 | Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2 |
Q33875700 | From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer |
Q29248201 | Functional activation of mutant p53V172F by platinum analogs in cisplatin-resistant human tumor cells is dependent on serine-20 phosphorylation |
Q90392099 | Functional relationship between p53 and RUNX proteins |
Q35273347 | Functional repair of p53 mutation in colorectal cancer cells using trans-splicing |
Q54962657 | G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of Plk1. |
Q21285144 | GSK-3β: A Bifunctional Role in Cell Death Pathways |
Q38078490 | Gene copy-number alterations: a cost-benefit analysis |
Q30828205 | Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies |
Q28385996 | Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles |
Q95277612 | Generation of Transgenic Cloned Buffalo Embryos Harboring the EGFP Gene in the Y Chromosome Using CRISPR/Cas9-Mediated Targeted Integration |
Q37619445 | Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma |
Q33557871 | Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population |
Q34574962 | Genetics of ribosomal proteins: "curiouser and curiouser" |
Q36004559 | Genome-wide studies of the transcriptional regulation by p53. |
Q34013555 | Genomic factors that shape craniofacial outcome and neural crest vulnerability in FASD. |
Q34734168 | Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation |
Q37397215 | Global Changes in Lipid Profiles of Mouse Cortex, Hippocampus, and Hypothalamus Upon p53 Knockout |
Q34533232 | Global effect of inauhzin on human p53-responsive transcriptome |
Q39076121 | Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1. |
Q35354504 | Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway |
Q36975008 | Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway |
Q34320186 | Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation |
Q38867373 | Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A. |
Q42712360 | HATs on for drug resistance |
Q37066459 | HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis |
Q36757053 | HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence |
Q34651638 | HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes |
Q39214706 | HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells |
Q38885415 | HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status |
Q37402028 | HIPK2 modulates p53 activity towards pro-apoptotic transcription |
Q36835624 | HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures |
Q38806847 | Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice |
Q50286692 | Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice |
Q39344424 | Harmonic oscillations in homeostatic controllers: Dynamics of the p53 regulatory system |
Q36476953 | Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation |
Q36580378 | Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis |
Q41058668 | Heterogeneity of p53 dependent genomic responses following ethanol exposure in a developmental mouse model of fetal alcohol spectrum disorder. |
Q34274477 | High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity |
Q33961759 | High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays |
Q34108945 | High-throughput transcriptome sequencing identifies candidate genetic modifiers of vulnerability to fetal alcohol spectrum disorders |
Q35178908 | Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium |
Q39672349 | Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression |
Q36601446 | How do K-RAS-activated cells evade cellular defense mechanisms? |
Q39565523 | Human EHMT2/G9a activates p53 through methylation-independent mechanism |
Q36738940 | Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1. |
Q28386709 | Human bronchial epithelial BEAS-2B cells, an appropriate in vitro model to study heavy metals induced carcinogenesis |
Q21263027 | Human single-stranded DNA binding proteins are essential for maintaining genomic stability |
Q27004438 | Hydrogen peroxide sensing, signaling and regulation of transcription factors |
Q35515340 | Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation |
Q38765522 | Hyperactivation of ATM upon DNA-PKcs inhibition modulates p53 dynamics and cell fate in response to DNA damage |
Q38882325 | Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells. |
Q24298359 | Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts |
Q47143807 | Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma |
Q47129006 | Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53. |
Q44871312 | Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions |
Q58588134 | Identification of kinases and interactors of p53 using kinase-catalyzed crosslinking and immunoprecipitation (K-CLIP) |
Q34154612 | Identification of lysine succinylation as a new post-translational modification |
Q41436986 | Identification of novel radiation-induced p53-dependent transcripts extensively regulated during mouse brain development |
Q38176221 | Illuminating p53 function in cancer with genetically engineered mouse models |
Q35111076 | Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53. |
Q61807497 | Impaired Expression of Rearranged Immunoglobulin Genes and Premature p53 Activation Block B Cell Development in BMI1 Null Mice |
Q28708952 | Implications of systemic dysfunction for the etiology of malignancy |
Q28475341 | In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML |
Q35762987 | Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice |
Q50083521 | Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice |
Q36149306 | Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth |
Q36801098 | Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents |
Q37406388 | Increased apoptosis rate of human decidual cells and cytotrophoblasts in patients with recurrent spontaneous abortion as a result of abnormal expression of CDKN1A and Bax. |
Q39508688 | Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice |
Q39336132 | Induction of ASAP (MAP9) contributes to p53 stabilization in response to DNA damage. |
Q28573948 | Inflammatory cells regulate p53 and caspases in acute pancreatitis |
Q36138010 | Influence of Human p53 on Plant Development |
Q34565153 | Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor |
Q90635071 | Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells |
Q35868154 | Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1. |
Q50421763 | Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects |
Q89739763 | Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity |
Q41810049 | Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3. |
Q36589313 | Inhibition of cancer cell proliferation by 5-fluoro-2'-deoxycytidine, a DNA methylation inhibitor, through activation of DNA damage response pathway |
Q38796979 | Inhibition of cell proliferation, migration and invasion by a glioma-targeted fusion protein combining the p53 C terminus and MDM2-binding domain |
Q33570316 | Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2 |
Q34009402 | Insulin receptor tyrosine kinase substrate enhances low levels of MDM2-mediated p53 ubiquitination. |
Q38322114 | Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer |
Q39418221 | Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma |
Q90604823 | Interaction with AEG-1 and MDM2 is associated with glioma development and progression and correlates with poor prognosis |
Q39723681 | Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. |
Q33656086 | Interplay between Mdm2 and HIPK2 in the DNA damage response |
Q35922756 | Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined |
Q34990640 | Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation |
Q35510300 | Intrinsically disordered proteins in cellular signalling and regulation. |
Q36006961 | Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation |
Q54303856 | Involvement of Wnt signaling in the injury of murine mesenchymal stem cells exposed to X-radiation. |
Q38162722 | Ionizing radiation-induced responses in human cells with differing TP53 status |
Q35131133 | JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation |
Q57805010 | K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay |
Q34409029 | KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes |
Q58544657 | KDM5A Regulates a Translational Program that Controls p53 Protein Expression |
Q57590598 | KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cells |
Q41949624 | Keeping p53 in check: a high-stakes balancing act. |
Q99712014 | Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy |
Q24306115 | Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation |
Q38738109 | Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells. |
Q49651549 | LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress |
Q42253318 | Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion |
Q37765653 | Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model. |
Q92316046 | Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation |
Q47107585 | Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells |
Q47138075 | Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions |
Q92423983 | Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer |
Q40652796 | Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53. |
Q45393476 | Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response |
Q54198378 | Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia. |
Q64106666 | Loss of SET reveals both the p53-dependent and the p53-independent functions in vivo |
Q34409141 | Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway |
Q37022020 | Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging |
Q28548585 | Low-Dose, Long-Wave UV Light Does Not Affect Gene Expression of Human Mesenchymal Stem Cells |
Q38019558 | Lysine methylation and the regulation of p53. |
Q37970950 | Lysine methylation: beyond histones |
Q38769335 | Lysines in the tetramerization domain of p53 selectively modulate G1 arrest |
Q55245371 | MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. |
Q34386033 | MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein |
Q85072453 | MDM4 overexpression contributes to synoviocyte proliferation in patients with rheumatoid arthritis |
Q38907224 | MDMX exerts its oncogenic activity via suppression of retinoblastoma protein |
Q35695025 | MG132 inhibition of proteasome blocks apoptosis induced by severe DNA damage |
Q90571091 | MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance |
Q40459014 | MKK7 and ARF: new players in the DNA damage response scenery. |
Q59326864 | MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance |
Q39078439 | Maintenance of pluripotency in mouse ES cells without Trp53. |
Q34503497 | Making sense of ubiquitin ligases that regulate p53 |
Q46063736 | Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases |
Q37465881 | Mathematical model of dynamic protein interactions regulating p53 protein stability for tumor suppression |
Q38059700 | Mdm2 and MdmX as Regulators of Gene Expression |
Q41287457 | Mdm2 and tumorigenesis: evolving theories and unsolved mysteries |
Q40680755 | Mdm2's dilemma: to degrade or to translate p53? |
Q39404029 | MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress |
Q35084991 | MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination |
Q39646906 | Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology |
Q28392953 | Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721 |
Q35900622 | Mechanisms of p53 activation and physiological relevance in the developing kidney. |
Q38865504 | Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction. |
Q43871288 | Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. |
Q37298047 | Metabolic regulation by p53 family members. |
Q60052866 | Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis |
Q64242213 | MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer |
Q36130066 | MiR-1246: a new link of the p53 family with cancer and Down syndrome |
Q38924922 | MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation |
Q40337181 | MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma |
Q38035144 | MicroRNAs in the p53 network: micromanagement of tumour suppression |
Q41281675 | Mild electrical stimulation at 0.1-ms pulse width induces p53 protein phosphorylation and G2 arrest in human epithelial cells. |
Q34328693 | Minichromosome maintenance 2 bound with retroviral Gp70 is localized to cytoplasm and enhances DNA-damage-induced apoptosis |
Q38587869 | Mitochondrial dynamics regulating chemoresistance in gynecological cancers |
Q28818349 | Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2 |
Q37725579 | Modeling amplified p53 responses under DNA-PK inhibition in DNA damage response |
Q91663732 | Modulation of p53 Transactivation Domain Conformations by Ligand Binding and Cancer-Associated Mutations |
Q28546597 | Modulation of the disordered conformational ensembles of the p53 transactivation domain by cancer-associated mutations |
Q41277033 | Modulation of the p53 family network by RNA-binding proteins |
Q26776299 | Molecular mechanisms of etoposide |
Q50934772 | Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner. |
Q37596373 | Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein. |
Q38616107 | Moonlighting proteins in cancer. |
Q33997232 | Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia |
Q33818479 | Mutant TP53 posttranslational modifications: challenges and opportunities. |
Q37665360 | NAD(+) Metabolism in Age-Related Hearing Loss |
Q41585790 | NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity |
Q41993999 | NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization. |
Q46292577 | NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression |
Q38061832 | NRF2 and p53: Januses in cancer? |
Q52579667 | Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation. |
Q34166515 | Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest. |
Q39077362 | Negative auto-regulators trap p53 in their web. |
Q37000550 | Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1). |
Q36156998 | Negative regulation of the p300-p53 interplay by DDX24. |
Q34142778 | Negative regulation of the tumor suppressor p53 gene by microRNAs. |
Q34153536 | Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage |
Q47299905 | Neonatal Exposure to 6-n-Propyl-Thiouracil, an Anti-Thyroid Drug, Alters Expression of Hepatic DNA Methyltransferases, Methyl CpG-Binding Proteins, Gadd45a, p53, and PCNA in Adult Male Rats |
Q26765483 | New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity |
Q34758670 | New insights into p53 activation |
Q38205171 | New insights into p53 functions through its target microRNAs |
Q38389967 | New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy. |
Q24622202 | Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms |
Q41993883 | Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy. |
Q37445903 | Novel HIV-1 therapeutics through targeting altered host cell pathways |
Q26777988 | Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2 |
Q24299137 | Novel nucleolar pathway connecting intracellular energy status with p53 activation |
Q42591177 | Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1) |
Q42424178 | Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop |
Q24595171 | Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol |
Q34379057 | OTUD5 regulates p53 stability by deubiquitinating p53. |
Q34149922 | Oncogenes and tumor suppressor genes |
Q26749382 | Oncogenic Intra-p53 Family Member Interactions in Human Cancers |
Q38156100 | Oncoprotein stabilization in brain tumors. |
Q59329506 | Orchestration of protein acetylation as a toggle for cellular defense and virus replication |
Q39453113 | Orphan nuclear receptor PNR/NR2E3 stimulates p53 functions by enhancing p53 acetylation |
Q38723764 | Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria |
Q38045766 | Overexpression of p53 protein in human tumors |
Q27024861 | Oxidative stress and pulmonary fibrosis |
Q38171333 | Oxygen regulates molecular mechanisms of cancer progression and metastasis |
Q37769295 | Oxygenomics in environmental stress. |
Q36522722 | P53 Regulates Rapid Apoptosis in Human Pluripotent Stem Cells. |
Q28586356 | PAC1 gene knockout reveals an essential role of chaperone-mediated 20S proteasome biogenesis and latent 20S proteasomes in cellular homeostasis |
Q47701502 | PANDAR: a pivotal cancer-related long non-coding RNA in human cancers |
Q92163668 | PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth |
Q46242652 | PEPD is a pivotal regulator of p53 tumor suppressor |
Q38842390 | PHD1 regulates p53-mediated colorectal cancer chemoresistance. |
Q39713494 | PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage. |
Q92459709 | PTEN arginine methylation by PRMT6 suppresses PI3K-AKT signaling and modulates pre-mRNA splicing |
Q42668728 | PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer |
Q54603551 | Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. |
Q46243356 | Pelargonidin Modulates Keap1/Nrf2 Pathway Gene Expression and Ameliorates Citrinin-Induced Oxidative Stress in HepG2 Cells |
Q52663744 | Peli1 modulates the subcellular localization and activity of Mdmx. |
Q26991867 | Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis |
Q92155477 | Peroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis |
Q51372112 | Persistent transcriptional responses show the involvement of feed-forward control in a repeated dose toxicity study. |
Q37366864 | Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma |
Q37191174 | Pharmacological activation of p53 in cancer cells |
Q36618617 | Pharmacological blockade of a β(2)AR-β-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model |
Q35196159 | Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53 |
Q35252479 | Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53 |
Q35149631 | Phosphorylation of Tip60 by p38α regulates p53-mediated PUMA induction and apoptosis in response to DNA damage |
Q28114977 | Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response |
Q35213271 | Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein |
Q26823798 | Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs) |
Q39763520 | Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation. |
Q55346775 | Plakoglobin restores tumor suppressor activity of p53R175H mutant by sequestering the oncogenic potential of β-catenin. |
Q37541596 | Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. |
Q36508707 | Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis |
Q33899450 | Posttranslational modification of p53: cooperative integrators of function |
Q52584348 | Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer. |
Q33595368 | Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. |
Q33594076 | Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens |
Q37978967 | Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia |
Q46477265 | Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis |
Q92565645 | Prognostic value of chloride channel accessory mRNA expression in colon cancer |
Q35813589 | Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response |
Q28239216 | Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response |
Q51129826 | Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a. |
Q37800060 | Protein acetylation within the cellular response to radiation. |
Q91825036 | Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice |
Q38266035 | Proteomics for systems toxicology |
Q28591824 | Puma is required for p53-induced depletion of adult stem cells |
Q37341983 | Punicalagin, a polyphenol in pomegranate juice, downregulates p53 and attenuates hypoxia-induced apoptosis in cultured human placental syncytiotrophoblasts |
Q38133962 | Push back to respond better: regulatory inhibition of the DNA double-strand break response |
Q42414248 | Putting the brakes on p53-driven apoptosis |
Q35665695 | RAD6 regulates the dosage of p53 by a combination of transcriptional and posttranscriptional mechanisms |
Q47860453 | RCC2 is a novel p53 target in suppressing metastasis |
Q39597077 | RNA content in the nucleolus alters p53 acetylation via MYBBP1A. |
Q34993091 | RNA polymerase III transcription in cancer: the BRF2 connection |
Q39456968 | RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance |
Q51097612 | RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras? |
Q38766269 | Radon-induced alterations in p53-mediated energy metabolism of malignantly transformed human bronchial epithelial cells |
Q36351105 | Rap2b siRNA significantly enhances the anticancer therapeutic efficacy of adriamycin in a gold nanoshell-based drug/gene co-delivery system |
Q36906255 | Rap2b, a novel p53 target, regulates p53-mediated pro-survival function |
Q34230578 | Rapid and sensitive detection of an intracellular pathogen in human peripheral leukocytes with hybridizing magnetic relaxation nanosensors |
Q42498067 | Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program |
Q41960009 | Reactivating the ARF-p53 axis in AML cells by targeting ULF. |
Q37233582 | Reactivation of mutant p53 by capsaicin, the major constituent of peppers |
Q28537881 | Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine |
Q38433099 | Real-time and simultaneous monitoring of the phosphorylation and enhanced interaction of p53 and XPC acidic domains with the TFIIH p62 subunit. |
Q92860226 | Reciprocal Crosstalk Between YAP1/Hippo Pathway and the p53 Family Proteins: Mechanisms and Outcomes in Cancer |
Q36756039 | Reciprocal regulation of RORγt acetylation and function by p300 and HDAC1. |
Q39256295 | Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner |
Q26740191 | Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy |
Q37861632 | Redox modulation of p53: mechanisms and functional significance |
Q36088612 | Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells. |
Q34771336 | Regulation of DNA damage responses and cell cycle progression by hMOB2. |
Q24294656 | Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4 |
Q39322285 | Regulation of Metabolic Activity by p53. |
Q26770579 | Regulation of Mutant p53 Protein Expression |
Q45316783 | Regulation of TP53 Activity |
Q45316786 | Regulation of TP53 Degradation |
Q38170004 | Regulation of cancer metabolism by O-GlcNAcylation |
Q34949637 | Regulation of cell differentiation by the DNA damage response |
Q57594615 | Regulation of p53 acetylation |
Q28510160 | Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage |
Q41838045 | Regulation of p53 during senescence in normal human keratinocytes. |
Q41908224 | Regulation of p53 in NIH3T3 mouse fibroblasts following hyperosmotic stress |
Q37992789 | Regulation of p53: a collaboration between Mdm2 and Mdmx |
Q29976922 | Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. |
Q37394276 | Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress |
Q38302449 | Regulation of the Tumor-Suppressor Function of the Class III Phosphatidylinositol 3-Kinase Complex by Ubiquitin and SUMO |
Q90706140 | Regulators of Oncogenic Mutant TP53 Gain of Function |
Q28066784 | Regulatory non-coding RNA: new instruments in the orchestration of cell death |
Q49916296 | Repair kinetics of DNA double-strand breaks and incidence of apoptosis in mouse neural stem/progenitor cells and their differentiated neurons exposed to ionizing radiation |
Q24337798 | Repression of Puma by scratch2 is required for neuronal survival during embryonic development |
Q36733743 | Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway |
Q39205536 | Reviving the guardian of the genome: Small molecule activators of p53. |
Q39385222 | Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress |
Q34178921 | Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis |
Q34850281 | Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network |
Q37690890 | Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer |
Q37612283 | Role of HDAC1 in senescence, aging, and cancer |
Q33828002 | Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis |
Q34085616 | Role of Pirh2 in mediating the regulation of p53 and c-Myc |
Q39283898 | Role of citrullination modification catalyzed by peptidylarginine deiminase 4 in gene transcriptional regulation. |
Q61801121 | Role of p53 in pseudorabies virus replication, pathogenicity, and host immune responses |
Q38203736 | Role of the lncRNA-p53 regulatory network in cancer |
Q42355766 | Roles of Polo-like kinase 3 in suppressing tumor angiogenesis. |
Q92257837 | Roles of p53 Family Structure and Function in Non-Canonical Response Element Binding and Activation |
Q37123340 | Roles of p53 in herpes simplex virus 1 replication |
Q34413441 | Roles of tumor suppressors in regulating tumor-associated inflammation |
Q24339585 | Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma |
Q53283601 | S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence. |
Q34313327 | S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde |
Q28509658 | S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response |
Q51011770 | SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress. |
Q24310032 | SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53 |
Q35064623 | SIRT1 Deficiency Downregulates PTEN/JNK/FOXO1 Pathway to Block Reactive Oxygen Species-Induced Apoptosis in Mouse Embryonic Stem Cells |
Q24297333 | SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60 |
Q37525832 | SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways |
Q39555703 | SMG7 is a critical regulator of p53 stability and function in DNA damage stress response. |
Q34316449 | SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity |
Q36544196 | STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation |
Q28594151 | SUMO-specific protease 2 in Mdm2-mediated regulation of p53 |
Q24301634 | SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage |
Q34077127 | Scintillation proximity assay for total p53 protein as an alternative to ELISA. |
Q38059701 | Scission of the p53-MDM2 Loop by Ribosomal Proteins |
Q41459790 | Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA. |
Q39484755 | Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells |
Q26828473 | Self-consumption: the interplay of autophagy and apoptosis |
Q35518170 | Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin. |
Q35206381 | Signaling to p53: ribosomal proteins find their way. |
Q36901939 | Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells |
Q28481334 | Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics |
Q41768808 | Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53 |
Q38993512 | SirT3 and p53 Deacetylation in Aging and Cancer |
Q34028698 | Sirt3 protects in vitro-fertilized mouse preimplantation embryos against oxidative stress-induced p53-mediated developmental arrest |
Q45738787 | Site-specific NMR mapping and time-resolved monitoring of serine and threonine phosphorylation in reconstituted kinase reactions and mammalian cell extracts. |
Q50575365 | Skeletal muscle stem cells adopt a dormant cell state post mortem and retain regenerative capacity. |
Q37839534 | Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. |
Q27014977 | Smoking, p53 mutation, and lung cancer |
Q37498910 | SnoN activates p53 directly to regulate aging and tumorigenesis |
Q37007086 | Sod1 loss induces intrinsic superoxide accumulation leading to p53-mediated growth arrest and apoptosis |
Q38262589 | Squaring up to DNA: pentapeptide repeat proteins and DNA mimicry |
Q38838490 | Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α. |
Q35178418 | Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells. |
Q36870100 | Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. |
Q36119624 | Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26. |
Q91850861 | Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes |
Q34475801 | Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR. |
Q27683532 | Structural basis for the site-specific incorporation of lysine derivatives into proteins |
Q27701526 | Structural basis of how stress-induced MDMX phosphorylation activates p53 |
Q28484540 | Structure and activity analysis of Inauhzin analogs as novel antitumor compounds that induce p53 and inhibit cell growth |
Q27658473 | Structure of the Taz2 domain of p300: insights into ligand binding |
Q36741049 | Structure, functional regulation and signaling properties of Rap2B. |
Q29994717 | Structures of closed and open conformations of dimeric human ATM |
Q27680171 | Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue |
Q34675969 | Suppression of p53 activity through the cooperative action of Ski and histone deacetylase SIRT1. |
Q35967111 | Surf the post-translational modification network of p53 regulation |
Q38821561 | Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis |
Q47160964 | Synthetic lethal genetic interactions between Rad54 and PARP-1 in mouse development and oncogenesis |
Q35274495 | T-cell intracellular antigens function as tumor suppressor genes |
Q36719443 | TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene |
Q41499355 | TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription |
Q37741025 | TGFbeta and cancer metastasis: an inflammation link. |
Q41991646 | TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency |
Q60916058 | TP53LNC-DB, the database of lncRNAs in the p53 signalling network |
Q38732652 | TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression |
Q33899861 | TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage |
Q37261753 | TRIMming p53 for ubiquitination |
Q90524104 | TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage |
Q34568811 | Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury |
Q59132125 | Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers |
Q36020398 | Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept |
Q48570977 | Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma |
Q38247168 | Targeting p53-MDM2-MDMX loop for cancer therapy |
Q38059739 | Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy |
Q33657519 | Targeting tumor suppressor networks for cancer therapeutics |
Q95301002 | Tau affects P53 function and cell fate during the DNA damage response |
Q34624486 | Tethering function of the caspase cleavage fragment of Golgi protein p115 promotes apoptosis via a p53-dependent pathway |
Q51060945 | The "readers" of unacetylated p53 represent a new class of acidic domain proteins. |
Q28507164 | The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo |
Q33870522 | The DNA damage response: the omics era and its impact |
Q33725241 | The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage |
Q91710491 | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents |
Q24298474 | The E3 ligase Smurf1 regulates Wolfram syndrome protein stability at the endoplasmic reticulum |
Q39005319 | The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization |
Q47215879 | The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †. |
Q42322261 | The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination. |
Q38329840 | The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. |
Q36980558 | The MDM2-p53-pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cells |
Q34030117 | The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor |
Q38888153 | The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. |
Q52715352 | The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest. |
Q57166264 | The Nucleolus |
Q47150239 | The Oncogenic Role of Tribbles 1 in Hepatocellular Carcinoma Is Mediated by a Feedback Loop Involving microRNA-23a and p53. |
Q94322163 | The Possible Crosstalk of MOB2 With NDR1/2 Kinases in Cell Cycle and DNA Damage Signaling |
Q35232574 | The RNA surveillance protein SMG1 activates p53 in response to DNA double-strand breaks but not exogenously oxidized mRNA. |
Q47307122 | The Roles of P53 and its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis Stage Mouse Embryos. |
Q36607243 | The TP53 fertility network |
Q99708992 | The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing |
Q36766027 | The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells |
Q34504101 | The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells |
Q33827703 | The complex landscape of pancreatic cancer metabolism |
Q38486293 | The critical molecular interconnections in regulating apoptosis and autophagy. |
Q37859721 | The dual role of p53: DNA protection and antioxidant. |
Q37665224 | The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder |
Q34554010 | The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro |
Q37897323 | The emerging role of Mule and ARF in the regulation of base excision repair |
Q26853164 | The functional diversity of protein lysine methylation |
Q38061848 | The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes |
Q34429176 | The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome |
Q39233244 | The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage |
Q40562742 | The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases |
Q34199692 | The impact of acetylation and deacetylation on the p53 pathway |
Q38786667 | The importance of p53 pathway genetics in inherited and somatic cancer genomes. |
Q28483781 | The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment |
Q35786347 | The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury |
Q34846077 | The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest. |
Q37526379 | The multiple levels of regulation by p53 ubiquitination |
Q30356852 | The next level of complexity: crosstalk of posttranslational modifications. |
Q38515093 | The nucleolar interface of RNA viruses |
Q37596345 | The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption |
Q24597470 | The nucleolus under stress |
Q37359180 | The origin of allosteric functional modulation: multiple pre-existing pathways |
Q35122947 | The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo |
Q34020353 | The p53 orchestra: Mdm2 and Mdmx set the tone |
Q27690770 | The p53 pathway as a target in cancer therapeutics: obstacles and promise |
Q35046887 | The p53 response in single cells is linearly correlated to the number of DNA breaks without a distinct threshold |
Q58780971 | The p53/Adipose-Tissue/Cancer Nexus |
Q33685413 | The regulation of the p53-mediated stress response by MDM2 and MDM4. |
Q45395590 | The ribosomal protein S26 regulates p53 activity in response to DNA damage |
Q96764448 | The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation |
Q36392179 | The transcription factor CREBZF is a novel positive regulator of p53. |
Q42917239 | The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism |
Q37762069 | The tumor suppressor p53: from structures to drug discovery |
Q24644208 | The ubiquitin proteasome system in neuropathology |
Q48000346 | The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities |
Q38795765 | The viral non-structural protein 1 alpha (Nsp1α) inhibits p53 apoptosis activity by increasing murine double minute 2 (mdm2) expression in porcine reproductive and respiratory syndrome virus (PRRSV) early-infected cells |
Q36833275 | Therapeutic targeting of the p53 pathway in cancer stem cells. |
Q41807243 | Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells |
Q41126970 | Tia1 dependent regulation of mRNA subcellular location and translation controls p53 expression in B cells. |
Q36889843 | Tissue Inhibitor of Matrix Metalloproteinases-1 Knockdown Suppresses the Proliferation of Human Adipose-Derived Stem Cells |
Q34838208 | Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function |
Q39242429 | Tissue-Specific Functions of p53 During Kidney Development |
Q35783751 | Towards an understanding of the role of p53 in adrenocortical carcinogenesis |
Q38838992 | Toxoplasma gondii Rhoptry Protein ROP16 Mediates Partially SH-SY5Y Cells Apoptosis and Cell Cycle Arrest by Directing Ser15/37 Phosphorylation of p53 |
Q35138721 | Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo |
Q38541481 | Transcription factors that interact with p53 and Mdm2 |
Q24301836 | Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses |
Q92636264 | Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence |
Q37777267 | Transcriptional regulation by p53. |
Q34171267 | Transcriptional repressor NIR functions in the ribosome RNA processing of both 40S and 60S subunits |
Q38594197 | Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2. |
Q38919143 | Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing |
Q39505445 | Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas |
Q96135302 | Trisenox Disrupts MDM2-DAXX-HAUSP Complex and Induces Apoptosis in a Mouse Model of Acute Leukemia |
Q35198383 | Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients. |
Q36161900 | Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line |
Q26992094 | Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling |
Q43120565 | Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence |
Q37412688 | Tumor suppressive functions of p53 |
Q33833892 | Tumor suppressor RASSF1A promoter: p53 binding and methylation |
Q44608082 | Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. |
Q28477217 | Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation |
Q38966981 | Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD |
Q39708546 | Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA. |
Q37810431 | Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention |
Q38824332 | Tumor-Suppressor Functions of the TP53 Pathway |
Q24295055 | Turning the RING domain protein MdmX into an active ubiquitin-protein ligase |
Q35022037 | Two-phase dynamics of p53 in the DNA damage response. |
Q36771960 | UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation |
Q38941587 | UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop. |
Q98513730 | UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination |
Q34696209 | USP11 regulates p53 stability by deubiquitinating p53. |
Q52723469 | USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells. |
Q24300434 | USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1 |
Q36944526 | USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation |
Q37577477 | USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis |
Q42714232 | USP7/HAUSP stimulates repair of oxidative DNA lesions |
Q36232109 | UXT, a novel MDMX-binding protein, promotes glycolysis by mitigating p53-mediated restriction of NF-κB activity |
Q34503492 | Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets |
Q39032658 | Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma |
Q39221079 | Ubiquitination/deubiquitination and acetylation/deacetylation: making DNMT1 stability more coordinated |
Q36485242 | Ubiquitylation of p53 by the APC/C inhibitor Trim39. |
Q35615172 | Uncovering ubiquitin and ubiquitin-like signaling networks |
Q37802195 | Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies |
Q38128769 | Unraveling DNA damage response-signaling networks through systems approaches |
Q52586740 | Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis. |
Q37380800 | Uptake, p53 pathway activation, and cytotoxic responses for Co(II) and Ni(II) in human lung cells: implications for carcinogenicity |
Q64950512 | Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer. |
Q33895858 | Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma |
Q37748214 | Using mice to examine p53 functions in cancer, aging, and longevity |
Q34209099 | Validation of MdmX as a therapeutic target for reactivating p53 in tumors |
Q35275179 | Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent |
Q64387425 | Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin |
Q33815907 | WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway |
Q33913340 | WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death |
Q39989125 | WTX: an unexpected regulator for p53. |
Q33947783 | Wheel running, skeletal muscle aerobic capacity and 1-methyl-1-nitrosourea induced mammary carcinogenesis in the rat. |
Q34248659 | When ribosomes go bad: diseases of ribosome biogenesis |
Q39030008 | Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ. |
Q35146343 | Wild type p53 reactivation: from lab bench to clinic. |
Q38266298 | Wip1 phosphatase in breast cancer |
Q35984061 | Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio |
Q58782264 | Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells |
Q89862470 | Working on Genomic Stability: From the S-Phase to Mitosis |
Q34441993 | XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313 |
Q36655029 | hSSB1 regulates both the stability and the transcriptional activity of p53 |
Q92508193 | iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition |
Q33998215 | mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexes |
Q58600725 | mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53 |
Q33599315 | miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines |
Q58918367 | p53 |
Q28085076 | p53 Acetylation: Regulation and Consequences |
Q37378360 | p53 E3 ubiquitin protein ligase homolog regulates p53 in vivo in the adult mouse eye lens |
Q37093496 | p53 Is a Host Cell Regulator during Herpes Simplex Encephalitis |
Q60907996 | p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value |
Q64071826 | p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX |
Q39242999 | p53 acetylation enhances Taxol-induced apoptosis in human cancer cells |
Q36882319 | p53 activation by Ni(II) is a HIF-1α independent response causing caspases 9/3-mediated apoptosis in human lung cells |
Q84583329 | p53 ancestry: gazing through an evolutionary lens |
Q34001316 | p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization |
Q37874926 | p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies |
Q39328814 | p53 and Sp1 cooperate to regulate the expression of Epstein-Barr viral Zta protein |
Q37510423 | p53 and p73 Regulate Apoptosis but Not Cell-Cycle Progression in Mouse Embryonic Stem Cells upon DNA Damage and Differentiation |
Q38255171 | p53 and the PWWP domain containing effector proteins in chromatin damage repair |
Q51761242 | p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. |
Q34029735 | p53 at a glance |
Q36052576 | p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes |
Q47096055 | p53 dynamics orchestrates with binding affinity to target genes for cell fate decision. |
Q35228392 | p53 in stem cells |
Q38540071 | p53 in survival, death and metabolic health: a lifeguard with a licence to kill |
Q24306453 | p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma |
Q36347218 | p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling |
Q87895880 | p53 keeps bystanders at the gates |
Q91701515 | p53 modifications: exquisite decorations of the powerful guardian |
Q35063064 | p53 negatively regulates RGS13 protein expression in immune cells |
Q30275107 | p53 pathway is involved in cell competition during mouse embryogenesis |
Q34300569 | p53 post-translational modification: deregulated in tumorigenesis |
Q46251110 | p53 promotes AKT and SP1-dependent metabolism through the pentose phosphate pathway that inhibits apoptosis in response to Nutlin-3a |
Q37882073 | p53 regulation by ubiquitin |
Q40715545 | p53 requires an intact C-terminal domain for DNA binding and transactivation |
Q35169245 | p53 requires the stress sensor USF1 to direct appropriate cell fate decision. |
Q35855525 | p53 staining correlates with tumor type and location in sebaceous neoplasms |
Q36567469 | p53 sumoylation: mechanistic insights from reconstitution studies |
Q39061575 | p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3. |
Q42371457 | p53 upregulates PLCε-IP3-Ca2+ pathway and inhibits autophagy through its target gene Rap2B. |
Q64106681 | p53 β-hydroxybutyrylation attenuates p53 activity |
Q42122625 | p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation. |
Q42362115 | p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance |
Q64921751 | p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin. |
Q44935692 | p53-Pathway activity and apoptosis in hydrogen sulfide-exposed stem cells separated from human gingival epithelium |
Q37727778 | p53-family proteins and their regulators: hubs and spokes in tumor suppression |
Q38247164 | p53-independent effects of Mdm2. |
Q34397020 | p53-mediated apoptosis requires inositol hexakisphosphate kinase-2 |
Q55322510 | p73 Alternative Splicing: Exploring a Biological Role for the C-Terminal Isoforms. |
Q28611414 | p73 as a pharmaceutical target for cancer therapy |
Q28590571 | p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response |
Q37163437 | β-Catenin C-terminal signals suppress p53 and are essential for artery formation |
Q28389986 | Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pat |
Search more.